Scarica l'app Stockscreener
8.58
4.24%
-0.38
Dopo l'orario di chiusura:
8.52
-0.06
-0.70%
Precedente Chiudi:
$8.96
Aprire:
$8.97
Volume 24 ore:
5.32M
Relative Volume:
0.62
Capitalizzazione di mercato:
$2.94B
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-24.51
EPS:
-0.35
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
-8.72%
1M Prestazione:
+14.86%
6M Prestazione:
+318.54%
1 anno Prestazione:
+231.27%
Intervallo 1D:
$8.27
$9.03
Intervallo di 1 settimana:
$8.27
$9.435
Portata 52W:
$1.54
$9.75
Nuvation Bio Inc Stock (NUVB) Company Profile
Nome
Nuvation Bio Inc
Settore
Industria
Telefono
(415) 754-3517
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Confronta NUVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
8.58 | 3.07B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-11-19 | Iniziato | B. Riley Securities | Buy |
| 2025-09-30 | Iniziato | Jefferies | Buy |
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-02 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2021-03-08 | Iniziato | BTIG Research | Buy |
| 2021-03-08 | Iniziato | Cowen | Outperform |
| 2021-03-08 | Iniziato | Jefferies | Buy |
| 2021-03-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
Nuvation Bio stock today: NUVB slides nearly 7% as early gains fade - ts2.tech
Nuvation Bio (NYSE:NUVB) Stock Price Down 5.4%Here's What Happened - MarketBeat
Nuvation Bio Inc. (NYSE:NUVB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Published on: 2025-12-23 19:34:24 - bollywoodhelpline.com
Nuvation Bio (NUVB) upgraded to buy: Here's what you should know - MSN
Nuvation Bio Earnings Notes - Trefis
Why Nuvation Bio Inc. Warrants stock gets analyst attentionJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда
How Nuvation Bio Inc. Warrants stock responds to bond marketInflation Watch & Weekly Watchlist for Hot Stocks - Улправда
Trading Recap: Will Nuvation Bio Inc. stock outperform growth indexes2025 Market WrapUp & AI Based Buy/Sell Signal Reports - Улправда
How Nuvation Bio Inc. stock reacts to oil pricesProfit Target & Safe Swing Trade Setup Alerts - Bölüm Sonu Canavarı
Wall Street Analysts Believe Nuvation Bio (NUVB) Could Rally 25.14%: Here's is How to Trade - Yahoo Finance
Is Nuvation Bio Inc. stock positioned for long term growthTrade Ideas & Expert Approved Momentum Ideas - DonanımHaber
Why Nuvation Bio Inc. stock is trending among retail tradersQuarterly Earnings Report & Short-Term High Return Ideas - DonanımHaber
How Nuvation Bio Inc. stock reacts to bond yieldsMarket Movement Recap & Fast Gaining Stock Reports - DonanımHaber
Why Nuvation Bio Inc. Class stock could be next leaderJuly 2025 Outlook & Reliable Entry Point Alerts - DonanımHaber
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week HighStill a Buy? - MarketBeat
Nuvation Bio stock hits 52-week high at 8.96 USD By Investing.com - Investing.com Canada
Nuvation Bio stock hits 52-week high at 8.96 USD - Investing.com
Will Nuvation Bio Inc. stock outperform growth indexesMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда
How buyback programs support Nuvation Bio Inc. Class stockJuly 2025 Momentum & Fast Exit/Entry Strategy Plans - Улправда
Nuvation Bio Sees Unusually Large Options Volume (NYSE:NUVB) - MarketBeat
Has Nuvation Bio’s 234% Surge in 2025 Already Reflected Its Growth Potential? - Yahoo Finance
Nuvation Bio (NUVB): Reassessing Valuation After a 78% Monthly Surge in the Share Price - Yahoo Finance
Is Nuvation Bio’s 228.6% 2025 Surge Still Supported by Valuation? - Sahm
Nuvation Bio (NUVB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
FY2025 EPS Estimates for Nuvation Bio Boosted by Analyst - MarketBeat
Gap Down: How Nuvation Bio Inc stock reacts to oil prices2025 EndofYear Setup & High Conviction Buy Zone Picks - moha.gov.vn
Nuvation Bio Inc. $NUVB Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Natixis Buys Shares of 905,500 Nuvation Bio Inc. $NUVB - MarketBeat
HC Wainwright & Co. maintains Nuvation Bio (NUVB) buy recommendation - MSN
Breakout Move: Why Nuvation Bio Inc stock is trending among retail tradersFed Meeting & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025? - ts2.tech
Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade - MarketBeat
Nuvation Bio Stock Surges Amid Price Target Boost - TipRanks
HC Wainwright Issues Positive Forecast for Nuvation Bio (NYSE:NUVB) Stock Price - MarketBeat
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright - Investing.com Nigeria
Institutional Investors in Nuvation Bio Inc. (NYSE:NUVB) Lost 6.3% Last Week but Have Reaped the Benefits of Longer-term Growth - 富途牛牛
HC Wainwright & Co. Maintains Nuvation Bio (NUVB) Buy Recommendation - Nasdaq
Nuvation Bio (NUVB): Reassessing Valuation After Safusidenib Data and Taletrectinib China Reimbursement News - Sahm
Nuvation Bio (NYSE:NUVB) Trading Down 5.9%Here's Why - MarketBeat
Nuvation Bio Inc. $NUVB is Omega Fund Management LLC's 4th Largest Position - MarketBeat
Nuvation Bio (NUVB) price target increased by 12.48% to 10.65 - MSN
Why Nuvation Bio (NUVB) Is Up 6.5% After Strong Safusidenib Phase 2 Glioma Data And What's Next - Sahm
Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL - Stock Titan
Nuvation Bio (NUVB) Price Target Increased by 12.48% to 10.65 - Nasdaq
Tema Etfs LLC Purchases Shares of 139,648 Nuvation Bio Inc. $NUVB - MarketBeat
Nuvation Bio Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Nuvation Bio (NUVB) bounces back 12% on impressive clinical trial result - MSN
Why Nuvation Bio Inc. Class stock is a strong analyst pickPortfolio Update Report & Verified Momentum Stock Alerts - Newser
Cash per share of Nuvation Bio Inc. – NYSE:NUVB - TradingView
Nuvation Bio Inc Azioni (NUVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):